TheraDoc
A leading provider of electronic clinical surveillance to healthcare organizations across the country.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
$117m Valuation: $117m | Acquisition | ||
| Total Funding | 000k | ||
Related Content
TheraDoc operates in the healthcare technology sector, providing advanced informatics solutions to hospitals and healthcare providers. The company specializes in real-time data analytics and predictive monitoring to improve patient outcomes, reduce healthcare-associated infections (HAIs), and enhance overall clinical performance. TheraDoc's core product suite includes tools for infection control, pharmacy assistance, and clinical surveillance, enabling healthcare teams to quickly identify, evaluate, and act on critical patient data. The business model is primarily subscription-based, offering software-as-a-service (SaaS) solutions that generate recurring revenue. TheraDoc serves a wide range of clients within the healthcare industry, including hospitals, clinics, and other healthcare facilities, primarily in the United States. The company makes money through subscription fees, licensing, and support services.
Keywords: healthcare technology, real-time data, predictive analytics, infection control, clinical surveillance, patient outcomes, SaaS, hospitals, healthcare providers, subscription-based.